首页> 外国专利> METHOD FOR OBTAINING SPECIFIC ANTIGENIC PREPARATIONS FROM CLINICALLY SIGNIFICANT YEAST FUNGI

METHOD FOR OBTAINING SPECIFIC ANTIGENIC PREPARATIONS FROM CLINICALLY SIGNIFICANT YEAST FUNGI

机译:从临床上具有重要意义的酵母菌中获取特定的抗生制剂的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely, immunology, and can be used to produce a specific protein-containing antigenic preparation from clinically significant yeast fungi. To this end, yeast from yeast species Candida albicans, either Geotrichum candidum, either Rhodotorula mucilaginosa, either Cryptococcus neoformans, either Trichosporon cutaneum is cultivated in a liquid synthetic nutrient medium. Cells are then separated by centrifugation and filtration, and the cell-free culture fluid is lyophilized, standardized for protein concentration and is used in immunochemical reactions to determine the level of specific antibodies to these mycosis pathogens. Analyzes are carried out by precipitation, ELISA with blood serum of patients with candidiasis. Prior to standardization, the culture fluid is further freed from polysaccharides and glycoproteins by repeated freezing-thawing and molecular filtration is carried out through a molecular filter with a pore diameter of 100 kDa. Specificity of the antigen preparation obtained is estimated under one of the conditions that: fraction of antigens with a molecular mass below 100 kDa from yeast species Candida albicans, either Geotrichum candidum, either Rhodotorula mucilaginosa, either Cryptococcus neoformans, either Trichosporon cutaneum interact only with homologous sera in patients with candidiasis, but does not interact with the sera of patients with candidiasis of another kind of yeast fungi; the levels of specific antibodies to the antigenic preparation in patients are higher than in the control group of patients without candidiasis.;EFFECT: use of this invention makes it possible to obtain specific protein-containing preparations from several genera of clinically significant yeast fungi, which makes it possible to determine the level of specific serum and epithelial immunoglobulins in the differential diagnosis of mycoses and mycoallergoses.;1 cl, 3 dwg, 3 tbl, 3 ex
机译:技术领域本发明涉及医学,即免疫学,并且可以用于从临床上重要的酵母真菌生产特定的含蛋白质的抗原制剂。为此,在液体合成营养培养基中培养来自白色念珠菌,白色念珠菌,粘液红假单胞菌,新隐球菌,皮肤毛滴虫的酵母。然后通过离心和过滤分离细胞,将无细胞的培养液冻干,标准化蛋白质浓度,并用于免疫化学反应以确定针对这些真菌病病原体的特异性抗体的水平。通过沉淀,ELISA对念珠菌病患者的血清进行分析。在标准化之前,通过反复冻融进一步使培养液不含多糖和糖蛋白,并通过孔径为100kDa的分子过滤器进行分子过滤。在以下条件之一下估计获得的抗原制剂的特异性:来自酵母物种白色念珠菌,念珠菌,粘液红球菌,新隐隐球菌,角质毛霉的仅分子量小于或等于100kDa的抗原部分念珠菌病患者的血清,但不与另一种酵母菌念珠菌病患者的血清相互作用;患者中针对抗原制剂的特异性抗体水平要高于没有念珠菌病的对照组。效果:本发明的使用使得可以从临床上具有重要意义的几种酵母真菌中获得含有特定蛋白质的制剂,可以确定特异性血清和上皮免疫球蛋白的水平,以鉴别诊断真菌病和霉菌变酶。1cl,3 dwg,3 tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号